Artiria Medical is a cutting-edge brand that is dedicated to reducing the mortality and morbidity associated with strokes. By utilizing a straightforward and minimally invasive approach, our mission is to address a significant unmet medical need. Artiria combines ongoing innovation with the renowned Swiss standards of quality, positioning ourselves as leaders in the development of next-generation products for endovascular surgeons.

Founded in 2019 as a spinoff of the prestigious Swiss Federal Institute of Technology Lausanne (EPFL), Artiria Medical is based in Switzerland. Our team consists of passionate professionals with extensive experience in mechanical, medical, and industrial Medtech fields. With a strong focus on collaboration and ingenuity, we work tirelessly to improve outcomes for stroke patients.

We pride ourselves on our commitment to excellence. Over the past four years, we have gathered valuable clinical feedback, accumulated 59 years of combined work experience in Medtech, and dedicated 624 hours to stress-testing our technology. Alongside our passionate team, we appreciate the support received from our partners and the funding received from the Swiss State Secretariat for Education, Research, and Innovation (SERI).

At Artiria Medical, we strive to make a profound impact in the lives of stroke patients through our innovative solutions and unwavering dedication to quality